πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6172061

Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative

Takeda Chemical Industries Ltd. Β· Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6172086

Methods and compositions for stimulating neurite growth

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6172089

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6171856

Methods and compositions relating to no-mediated cytotoxicity

The Board of Regents of the University of Texas System Β· Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6169074

Peptide inhibitors of neurotransmitter secretion by neuronal cells

The Regents of the University of California Β· Granted Tue Jan 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6167888

Method for inducing partial recovery of lost voluntary motor function after spinal cord in

The Regents of the University of California Β· Granted Tue Jan 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6169068

Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives

Regents of the University of Minnesota Β· Granted Tue Jan 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6169099

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Jan 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6169100

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Jan 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6166079

DFMO for the treatment or prevention of cervical intraepithelial neoplasia

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6166043

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165745

Recombinant production of immunoglobulin-like domains in prokaryotic cells

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165738

Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylas

Montech Medical Developments Pty. Ltd. Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6166042

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165484

EDTA and other chelators with or without antifungal antimicrobial agents for the preventio

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165460

Generation of immune responses to prostate-specific antigen (PSA)

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165440

Radiation and nanoparticles for enhancement of drug delivery in solid tumors

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165781

Modified adeno-associated virus vector capable of expression from a novel promoter

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165794

Suppression of proteolytic activity by dysfunctional protease formation

The Regents of the University of California Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6162445

Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6162815

RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6162787

Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, an

Immudyne, Inc. Β· Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6162620

Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines,

Cogent Partners, LP Β· Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6162432

Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired